Wellington Management Group Portfolio holdings
Wellington Management Group, founded in 1928 by Walter L. Morgan and headquartered in Boston, Massachusetts, is one of the world’s largest independent asset management firms, overseeing trillions in assets for a diverse client base including pension funds, endowments, and mutual fund investors. Renowned for its active management approach, Wellington offers a broad range of investment strategies across equities, fixed income, multi-asset, and alternative investments, emphasizing deep research and long-term partnerships with clients. The firm gained early fame for launching the Wellington Fund, one of the first balanced mutual funds, and has since maintained a reputation for disciplined, collaborative portfolio management. With a global presence and a focus on customized solutions, Wellington remains a trusted name in institutional and retail investing.
Top Buys
| 1 |
Broadcom
AVGO
|
+$2.06B |
| 2 |
Nasdaq
NDAQ
|
+$1.76B |
| 3 |
Wells Fargo
WFC
|
+$1.1B |
| 4 |
Gilead Sciences
GILD
|
+$978M |
| 5 |
Edwards Lifesciences
EW
|
+$964M |
Top Sells
| 1 |
EOG Resources
EOG
|
+$1.82B |
| 2 |
Apple
AAPL
|
+$1.75B |
| 3 |
HCA Healthcare
HCA
|
+$1.51B |
| 4 |
SPDR S&P 500 ETF Trust
SPY
|
+$1.48B |
| 5 |
PNC Financial Services
PNC
|
+$1.29B |
Sector Composition
| 1 | Technology | 23.24% |
| 2 | Healthcare | 19.6% |
| 3 | Financials | 13.95% |
| 4 | Consumer Discretionary | 9.41% |
| 5 | Industrials | 9.13% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1476
Enliven Therapeutics
ELVN
$1.19B
| $1.79M | ﹤0.01% |
70,170
+36,267
| +107% | +$926K |
|
1477
Oric Pharmaceuticals
ORIC
$1.02B
| $1.79M | ﹤0.01% |
174,388
+51,565
| +42% | +$529K |
|
1478
Consumers Staples Select Sector SPDR Fund
XLP
$16.1B
| $1.78M | ﹤0.01% |
+21,476
| New | +$1.78M |
|
1479
BP
BP
$87.8B
| $1.78M | ﹤0.01% |
56,610
-1,534,433
| -96% | -$48.2M |
|
1480
Cullinan Oncology
CGEM
$403M
| $1.77M | ﹤0.01% |
106,025
+33,927
| +47% | +$568K |
|
1481
BridgeBio Pharma
BBIO
$10.4B
| $1.77M | ﹤0.01% |
69,586
-1,400,524
| -95% | -$35.7M |
|
1482
Oshkosh
OSK
$8.7B
| $1.75M | ﹤0.01% |
17,477
+1,665
| +11% | +$167K |
|
1483
Arcellx
ACLX
$4B
| $1.75M | ﹤0.01% |
20,968
+2,768
| +15% | +$231K |
|
1484
UroGen Pharma
URGN
$991M
| $1.74M | ﹤0.01% |
137,300
-18,778
| -12% | -$238K |
|
|
WBA
1485
DELISTED
Walgreens Boots Alliance
WBA
| $1.73M | ﹤0.01% |
193,526
+127,558
| +193% | +$1.14M |
|
|
CWBC
1486
Community West Bancshares
CWBC
$406M
| $1.72M | ﹤0.01% |
89,333
| – | – |
|
1487
Applied Therapeutics
APLT
$63.4M
| $1.72M | ﹤0.01% |
+201,966
| New | +$1.72M |
|
1488
TG Therapeutics
TGTX
$5.08B
| $1.71M | ﹤0.01% |
73,320
+8,249
| +13% | +$193K |
|
1489
European Wax Center
EWCZ
$174M
| $1.7M | ﹤0.01% |
250,000
-2,994,295
| -92% | -$20.4M |
|
1490
Tourmaline Bio
TRML
$1.22B
| $1.69M | ﹤0.01% |
65,741
+27,707
| +73% | +$712K |
|
1491
Bioceres Crop Solutions
BIOX
$135M
| $1.69M | ﹤0.01% |
214,373
-31,461
| -13% | -$248K |
|
1492
Polaris
PII
$3.35B
| $1.68M | ﹤0.01% |
20,236
+2,019
| +11% | +$168K |
|
1493
Stoke Therapeutics
STOK
$1.21B
| $1.68M | ﹤0.01% |
136,975
-6,661
| -5% | -$81.9K |
|
|
VERV
1494
DELISTED
Verve Therapeutics
VERV
| $1.68M | ﹤0.01% |
347,029
-24,271
| -7% | -$117K |
|
1495
Pilgrim's Pride
PPC
$10.6B
| $1.66M | ﹤0.01% |
36,083
+2,682
| +8% | +$124K |
|
1496
Atlanticus Holdings
ATLC
$1.03B
| $1.65M | ﹤0.01% |
+47,157
| New | +$1.65M |
|
1497
Citizens Community Bancorp
CZWI
$163M
| $1.65M | ﹤0.01% |
116,644
| – | – |
|
1498
News Corp Class A
NWSA
$16.9B
| $1.65M | ﹤0.01% |
61,877
-57,477
| -48% | -$1.53M |
|
1499
Farmers National Banc Corp
FMNB
$568M
| $1.65M | ﹤0.01% |
108,917
| – | – |
|
1500
SPDR S&P Regional Banking ETF
KRE
$4.23B
| $1.64M | ﹤0.01% |
29,048
-856,451
| -97% | -$48.5M |
|